FIBROBODY

Owners

Goods & Services

Medical services, namely, in vitro analysis for medical and pharmaceutical use; medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the internet relating to pharmaceutical products

Pharmaceutical preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; biochemical medicines for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents consisting of compounds that facilitate delivery of pharmaceutical preparations

Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease

Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology